White House vaccine chief praises Biden’s plan to ask Americans to wear masks for first 100 days


“I think it’s a good idea. It’s never too late. This epidemic is plaguing the country. We all need to be careful, wear masks, wash our hands, keep our distance, be aware that this virus is a killer.” Slow told CNN’s Jack Tapper on “State the Union.”

He added, “We have a vaccine. There is light at the end of this tunnel, but we can’t all get the vaccine in our hands before May or June, so we need to be very careful and vigilant.”

Biden acknowledges that his authority to enforce the mask order is limited and relies heavily on the cooperation of state and local leaders, which can pose a challenge in Republican-run places, as many of the party’s elected leaders have resisted implementation amid a worsening epidemic. Order the mask.

The Republican lieutenant governor of Georgia told Tapper at the event Sunday that Biden’s plan is “a great step in the right direction,” but that the reality of “being forced to wear a mask” in every warm-up and cranny is not appropriate. ”

“Certainly wherever I go, especially in crowds, people will be encouraged to wear their masks,” said Lt. Govt. ”

U.S. Department of Disease Control and Prevention The centers said on Friday that masks are “complex” to control the spread of the virus, including at home.

Vaccine distribution

Sloe said Sunday that he expects the U.S. Food and Drug Administration to authorize emergency use of the vaccine manufactured by Pfizer after a meeting of its vaccine and related biological products advisory committee on Thursday. The FDA has said it is considering the EU, not full approval – a procedure that will take months – for the coronavirus vaccine.

“I expect that I recommend approval based on what I know. And I found that the vaccine is very effective, the vaccine is safe, its safety profile is comparable to many other vaccines that have been used for years,” he said. .

“Overall, I really hope they do it quickly and this vaccine will be available to our population starting this weekend,” Sloe added.

While Sloan used the term approval, the FDA thinks it is short of full approval. The FDA has said it will need closer to the full approval standard for the coronavirus vaccine, but will use the official route of emergency rapid use when companies provide all the information needed for the full approval process, known as the Biolox License Application or BLA. .

The agency will meet again next week with the advisory committee to review the vaccine application submitted by Moderna.

Sloan said once the vaccine is ready for delivery, it will be given to health care workers and people in long-term care facilities such as nursing homes, with the hope that most of it will be received in the coming weeks.

“Unfortunately, about 40 to 50% of deaths occur in older people who are in care homes,” he said. “We need to be able to vaccinate the entire population and the health care workers who care for them by the end of December or by mid-January.”

And in mid-March, Sloan said, “a very vulnerable population – about 100 million people” should be vaccinated.

Explanation: This story has been updated by the FDA to clarify Sloan’s quote on Pfizer’s consideration of the vaccine. She is considering authorizing emergency use this week.

CNN’s Michael Werner, Dan Marika and Tara Subramaniam contributed to this report.

.